Table 5 Characteristics of the included study populations
PROM | Reference | Sample size | Age mean (SD) or median in years | Setting | Country (Language) | Measurement properties |
|---|---|---|---|---|---|---|
Quality of life | ||||||
SNOT-16 | Garbutt et al. (2011) | N = 166 | 32 (range 18–69) | Primary care practices | USA (English) | Internal consistency, test-retest reliability, construct validity, responsiveness |
Quadri et al. (2013) | N = 347 | Treatment arm: 40.1 (13.8); Placebo arm: 40.3 (13.0) | Clinical sites | USA (English) | Internal consistency, construct validity, responsiveness | |
MARS | Hornáčková et al. (2014) | N = 100 | Patient group: 40.4 (range 18–71); Control group: 22.8 | Ears, nose, throat offices and outpatient department of a university hospital | Czech Republic (Czech) | PROM development, internal consistency, construct validity, responsiveness |
RhinoQoL | Petrat (2020) | N = 81 | ≥ 18 years | Clinical site | Germany (German) | Internal consistency, construct validity, responsiveness |
Symptoms | ||||||
PRSS | Shaikh et al. (2019) | Development: N = 258; Validation: N = 185 | Development: 6.4 (2.9), Validation: 5.6 (2.7) | Ambulatory pediatric clinics | USA (English) | PROM development, structural validity, internal consistency, test-retest reliability, responsiveness |
S5 | Garbutt et al. (1999) | Development: N = 1611; Validation: N = 93 | 46% <6 years; 26% 6–12 years; 27% >12 years | Community pediatric ambulatory care practice | USA (English) | PROM development, test-retest reliability, responsiveness |